Pulmonary vascular disorders in portal hypertension

被引:234
作者
Herve, P
Lebrec, D
Brenot, F
Simonneau, G
Humbert, M
Sitbon, O
Duroux, P
机构
[1] Hop Antoine Beclere, Serv Pneumol & Reanimat, Clamart, France
[2] Hop Beaujon, Lab Hemodynam Splanchn & Biol Vasc, INSERM, Clichy, France
关键词
cirrhosis; hepatopulmonary syndrome; hypoxaemia; portal hypertension; pulmonary hypertension;
D O I
10.1183/09031936.98.11051153
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The wide spectrum of pulmonary vascular disorders in liver disease and portal hypertension ranges from the hepatopulmonary syndrome characterized by intrapulmonary vascular dilatations, to pulmonary hypertension (portopulmonary hypertension), in which pulmonary vascular resistance is elevated, Since hepatopulmonary syndrome and portopulmonary hypertension have been reported in patients with nonhepatic portal hypertension,the common factor that determines their development must be portal hypertension. The clinical presentations are very different, with gas exchange impairment in the hepatopulmonary syndrome and haemodynamic failure in portopulmonary hypertension. The severity of hepatopulmonary syndrome stems to parallel the severity of liver failure, whereas no simple relationship has been identified between hepatic impairment and the severity of portopulmonary hypertension. Resolution of hepatopulmonary syndrome is common after liver transplantation, which has an uncertain effect in portopulmonary hypertension. The pathophysiology of both syndromes may involve vasoactive mediators and angiogenic factors.
引用
收藏
页码:1153 / 1166
页数:14
相关论文
共 88 条
[1]   Appetite-suppressant drugs and the risk of primary pulmonary hypertension [J].
Abenhaim, L ;
Moride, Y ;
Brenot, F ;
Rich, S ;
Benichou, J ;
Kurz, X ;
Higenbottam, T ;
Oakley, C ;
Wouters, E ;
Aubier, M ;
Simonneau, G ;
Begaud, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) :609-616
[2]   DIAGNOSTIC UTILITY OF CONTRAST ECHOCARDIOGRAPHY AND LUNG PERFUSION SCAN IN PATIENTS WITH HEPATOPULMONARY SYNDROME [J].
ABRAMS, GA ;
JAFFE, CC ;
HOFFER, PB ;
BINDER, HJ ;
FALLON, MB .
GASTROENTEROLOGY, 1995, 109 (04) :1283-1288
[3]   Mechanisms of gas exchange impairment in patients with liver cirrhosis [J].
Agusti, AG ;
Roca, J ;
RodriguezRoisin, R .
CLINICS IN CHEST MEDICINE, 1996, 17 (01) :49-+
[4]   ENHANCED ENDOTHELIUM-DEPENDENT VASODILATION IN PATIENTS WITH CIRRHOSIS [J].
ALBILLOS, A ;
ROSSI, I ;
CACHO, G ;
MARTINEZ, MV ;
MILLAN, I ;
ABREU, L ;
BARRIOS, C ;
ESCARTIN, P .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1995, 268 (03) :G459-G464
[5]   PARADOXICAL CONSTRICTION TO PLATELETS BY ARTERIES FROM RATS WITH PULMONARY-HYPERTENSION [J].
ASHMORE, RC ;
RODMAN, DM ;
SATO, K ;
WEBB, SA ;
OBRIEN, RF ;
MCMURTRY, IF ;
STELZNER, TJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (06) :H1929-H1934
[6]   Resolution of gas exchange abnormalities and intrapulmonary shunting following liver transplantation [J].
Battaglia, SE ;
Pretto, JJ ;
Irving, LB ;
Jones, RM ;
Angus, PW .
HEPATOLOGY, 1997, 25 (05) :1228-1232
[7]   BLOOD AND PLASMA 5-HYDROXYTRYPTAMINE LEVELS IN PATIENTS WITH CIRRHOSIS [J].
BEAUDRY, P ;
HADENGUE, A ;
CALLEBERT, J ;
GAUDIN, C ;
SOLIMAN, H ;
MOREAU, R ;
LAUNAY, JM ;
LEBREC, D .
HEPATOLOGY, 1994, 20 (04) :800-803
[8]   ARTERIAL CHANGES IN LUNGS IN CIRRHOSIS OF LIVER - LUNG SPIDER NEVI [J].
BERTHELO.P ;
WALKER, JG ;
SHERLOCK, S ;
REID, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1966, 274 (06) :291-&
[9]  
BRENOT F, 1997, PRIMARY PULMONARY HY, V99, P131
[10]   STIMULATION OF MIGRATION OF HUMAN AORTIC SMOOTH-MUSCLE CELLS BY VITRONECTIN - IMPLICATIONS FOR ATHEROSCLEROSIS [J].
BROWN, SL ;
LUNDGREN, CH ;
NORDT, T ;
FUJII, S .
CARDIOVASCULAR RESEARCH, 1994, 28 (12) :1815-1820